IVF & Reproductive Health: Market Growth, AI Innovation & Talent Trends

Ever Evolving IVF & Reproductive Health Landscape

Over the past few years, the IVF and reproductive health sector has transformed from a niche clinical service into a fast-growing, innovation-driven global industry.

Here’s how we see the current landscape, the forces reshaping it, and what talent leaders should prepare for:

Market Growth

• The ART market is projected to grow from ~US$27.6bn in 2023 to ~US$41.4bn by 2030 (~6% CAGR).
• The global IVF devices and consumables market is estimated at US$3.84bn in 2025, expected to reach ~US$8.4bn by 2030 (~17% CAGR).
• Time-lapse embryo imaging devices were worth ~US$1.53bn in 2024 and are forecast to more than double by 2035.

Geographic Drivers

• Asia-Pacific: Surging ART adoption driven by high infertility rates, improving healthcare infrastructure, and medical tourism.
• North America: Leading in innovation, regulation, and AI-driven fertility technologies.
• Europe: Strong in regulatory-led innovation and increasing AI adoption within IVF laboratories.

Innovation Trends

The future of fertility MedTech is digital, data-rich, and increasingly AI-enabled:

• AI-powered embryo assessment to improve viability predictions.
• Time-lapse imaging combined with cloud analytics for more accurate grading.
• Non-invasive genetic and viability screening using AI and imaging technologies.
• Machine-learning tools for sperm quality analysis.
• Deep learning models predicting live-birth outcomes based on historic clinical data.

Talent & Strategy Impacts

• Leadership: Demand for hybrid expertise across embryology, AI, regulation, and commercial strategy.
• Lab Operations: Leaders must manage automation, AI integration, and data governance.
• Regulatory: Compliance (MDR, FDA), ethics, and data privacy remain central.
• Commercial & Innovation: Leaders who can bridge AI platforms, device-genetics, and global service models are critical.

Outlook & Opportunities

• Growth markets include Asia, Latin America, and the Middle East, all primed for ART expansion.
• Patient-centric care is evolving through telehealth, remote hormone monitoring, and fertility apps.

Key Players

CooperSurgical Fertility Solutions | Vitrolife (Vitrolife Group) | AIVF | Virtus Health | Esco Medical | Nexpring Health | Genea Biomedx | Fairtility | Conceivable Life Sciences | U-Ploid Biotechnologies | Gameto | Kitazato | Kindbody | IVI RMA Global

If your organisation is scaling in the fertility and reproductive health sector, let’s connect. Our team supports with market intelligence, talent benchmarking, and targeted executive search.